Valeant Pharmaceuticals International Sr Financial Analyst Salaries in Tampa, FL
The average Valeant Pharmaceuticals International Sr Financial Analyst in Tampa, FL earns an estimated $90,944 annually, which includes an estimated base salary of $79,192 with a $11,752 bonus. Valeant Pharmaceuticals International's Sr Financial Analyst compensation is $3,536 more than the US average for a Sr Financial Analyst. Sr Financial Analyst salaries at Valeant Pharmaceuticals International in Tampa, FL can range from $31,500 - $310,000.
In Tampa, FL, The Finance Department at Valeant Pharmaceuticals International earns $828 more on average than the IT Department.
Last updated 2 years ago.
- $79,192
- avg. base
- $11,752
- avg. bonus
Sr Financial Analyst Salaries at Valeant Pharmaceuticals International
In Tampa, FL, Sr Financial Analysts earn $3,378 more than Financial Analysts, and $2,241 less than Senior Accountants.
Compensation at Valeant Pharmaceuticals International by Department
In Tampa, FL, The Finance Department averages $828 more than the IT Department, and $29,411 less than the HR Department
Sr Financial Analyst Compensation by Gender (All Companies)
The average female Sr Financial Analyst at companies similar size to Valeant Pharmaceuticals International reported making $93,556, while the average male Sr Financial Analyst at similar sized companies reported making $91,853.
Sr Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Sr Financial Analyst at companies similar size to Valeant Pharmaceuticals International reported making $98,729, while the average Native American Sr Financial Analyst at similar sized companies reported making $60,000.
How Sr Financial Analysts at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Sr Financial Analysts at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Sr Financial Analysts at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
